Test whether first-time vancomycin dosing works right
Treatments studied
Part of Infections clinical trials.
This study looks at giving vancomycin continuously in the ICU or orthopedics for the first time, to see if the dosing is done correctly. If you’re an adult receiving this treatment, the trial may help improve how safely and accurately vancomycin is managed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (not a child).
- You are receiving continuous vancomycin treatment in the ICU or an orthopedics unit.
- You (or your legal representative) can understand the study and sign the consent form.
- You do not have a history of organ or tissue transplantation.
- You are not on continuous kidney replacement therapy (CRRT).
- You are not on a heart-lung machine called ECMO.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study tests a new antibiotic called vancomycin to understand how the body reacts to it and identify early warning signs. If you qualify, you'll help researchers learn more about sudden allergic-like reactions that aren't traditional allergies.
This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.
This trial studies how to give the right dose of common antibiotics to children on ECMO (a heart-lung bypass machine). The goal is to help doctors choose the best dose to fight infections while keeping the child safe.
This trial compares two ways of dosing vancomycin (an antibiotic) for serious MRSA infections by using different blood test targets. The goal is to see if the newer approach works at least as well as the standard one, while keeping patients safe.
This study tests a personalized dosing approach for the antibiotic vancomycin given to patients in the neurological ICU. It aims to find the right dose for each patient to improve treatment and reduce side effects.
This trial studies a better way to monitor and adjust vancomycin (an antibiotic) dosing in very young infants. It may help your baby get the right dose while reducing the risk of under- or over-dosing.
Hear when a new Vancomycin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.